FeesSafety
Pluang+

California Water Service Group posts strong Q3 2026 with $65.4M net income and expands infrastructure investments.

Company Fundamentals
29 Oct 2026, 04:15 WIB
GlobeNewsWire
View Source
Bullish
California Water Service Group posts strong Q3 2026 with $65.4M net income and expands infrastructure investments.

California Water Service Group reported solid Q3 2026 results, with net income rising to $65.4 million and diluted EPS of $1.05, driven by revenue growth from rate changes and new customers. The company invested $148.3 million in water infrastructure and secured regulatory approvals for rate increases and acquisitions in multiple states. It also declared its 327th consecutive quarterly dividend and plans to close acquisitions in Nevada and Oregon by year-end. The strong financials and ongoing investments position the company to enhance water service quality and sustainability while maintaining affordability for customers.

California Water Service Group's Q3 2026 results provide context for readers following utilities stocks. For readers following utilities sector stocks on Pluang, here is the market snapshot as of Oct 29, 2026 05:02 WIB: out of 40 priced US utilities stocks, 17 rose and 23 fell. Notable movers include EVRG at USD 84.27 with a 1-day change of -1.21%, EIX at USD 58.89 with +1.20%, and CMS at USD 68.22 with -1.17%. Typical hold times on Pluang range from 10 to 20 days for these stocks.

More News

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

Global music market to grow at 8.07% CAGR, reaching $57.74B by 2032 driven by streaming and digital access.

The global music market is projected to grow from $36.13 billion in 2026 to $57.74 billion by 2032, at a CAGR of 8.07%, fueled by paid streaming subscriptions, smartphone adoption, and digital music discovery. North America remains the largest market...

Market News
Bullish
12 minutes ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
2 hours ago
China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
2 hours ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
2 hours ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App